DEFINITIVE PROXY STATEMENT

Company

60 DEGREES PHARMACEUTICALS, INC.

Filed

May 30, 2024

Period of Report

July 16, 2024

Accession Number

0001213900-24-047861

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →